文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症后的高费用使用者:一项基于人群的观察性队列研究

High-cost users after sepsis: a population-based observational cohort study.
PubMed 文献 · Crit Care · 2024-10-21
一句话结论脓毒症存活者出院后成为持续高费用使用者的风险约为无脓毒症者的2倍,且高费用状态持续时间更长。

该研究利用加拿大安大略省关联卫生行政数据库,纳入2016年1月至2017年12月期间住院并存活出院的成人,采用倾向评分加权构建基于人群的队列,比较脓毒症与非脓毒症患者出院后成为持续高费用使用者(连续90天处于总医疗支出前5%或前1%)的比例及随访期间处于高费用状态的时间占比。结果显示,脓毒症患者出院后任意时间连续90天处于前5%高费用使用者的OR为2.24(95%CI 2.04-2.46),平均42.3%的随访时间处于前5%高费用状态,而非脓毒症者为28.9%(RR 1.46;95%CI 1.45-1.48);处于前1%高费用状态的比例为10% vs 5.1%(OR 2.05;95%CI 2.99-2.11,原文此处写作2.99-2.11,按上下文应为1.99-2.11),时间占比为18.5% vs 10.8%(RR 1.68;95%CI 1.65-1.70)。结论提示脓毒症后遗症带来更高的医疗费用,具有重要经济影响。

要点

  • 脓毒症存活者出院后任意时间连续90天处于总医疗支出前5%高费用使用者的OR为2.24(95%CI 2.04-2.46),高于无脓毒症住院者。
  • 脓毒症患者出院后平均42.3%的随访时间处于前5%高费用状态,无脓毒症者为28.9%(RR 1.46;95%CI 1.45-1.48)。
  • 脓毒症患者出院后连续90天处于前1%高费用使用者的比例为10%,无脓毒症者为5.1%(OR 2.05;95%CI 2.99-2.11,原文此处写作2.99-2.11,按上下文应为1.99-2.11)。
  • 脓毒症患者处于前1%高费用状态的时间占比为18.5%,无脓毒症者为10.8%(RR 1.68;95%CI 1.65-1.70)。

适用人群与场景

  • 加拿大安大略省2016年1月至2017年12月期间住院并存活出院的成人。
  • 脓毒症通过经验证的算法识别。

诊断标准与关键阈值

  • 持续高费用使用者定义为出院后连续90天处于总医疗支出前5%或前1%。

研究设计与关键结果

  • 研究类型:基于人群的倾向评分加权队列研究,使用关联卫生行政数据库。
  • 样本量:共927,057例住院存活者,其中79,065例有脓毒症。
  • 主要终点:脓毒症患者出院后任意时间连续90天处于前5%高费用使用者的OR为2.24(95%CI 2.04-2.46);平均42.3%的随访时间处于前5%高费用状态,无脓毒症者为28.9%(RR 1.46;95%CI 1.45-1.48)。
  • 次要终点:脓毒症患者连续90天处于前1%高费用使用者的比例为10%,无脓毒症者为5.1%(OR 2.05;95%CI 2.99-2.11,原文此处写作2.99-2.11,按上下文应为1.99-2.11);处于前1%高费用状态的时间占比为18.5%,无脓毒症者为10.8%(RR 1.68;95%CI 1.65-1.70)。

证据类型、等级与局限

  • 证据类型:基于人群的观察性队列研究(倾向评分加权)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脓毒症后遗症导致更高的医疗费用并具有重要经济影响;脓毒症存活者出院后比无脓毒症住院者更可能成为高费用使用者且高费用状态持续时间更长。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: High-cost users (HCU) represent important targets for health policy interventions. Sepsis is a life-threatening syndrome that is associated with high morbidity, mortality, and economic costs to the healthcare system. We sought to estimate the effect of sepsis on being a subsequent HCU.

METHODS: Using linked health-administrative databases, we conducted a population-based, propensity score-weighted cohort study of adults who survived a hospitalization in Ontario, Canada between January 2016 and December 2017. Sepsis was identified using a validated algorithm. The primary outcome was being a persistent HCU after hospital discharge (in the top 5% or 1% of total health care spending for 90 consecutive days), and the proportion of follow-up time since discharge as a HCU.

RESULTS: We identified 927,057 hospitalized individuals, of whom 79,065 had sepsis. Individuals who had sepsis were more likely to be a top 5% HCU for 90 consecutive days at any time after discharge compared to those without sepsis (OR 2.24; 95% confidence interval [CI] 2.04-2.46) and spent on average 42.3% of their follow up time as a top 5% HCU compared to 28.9% of time among those without sepsis (RR 1.46; 95% CI 1.45-1.48). Individuals with sepsis were more likely to be a top 1% HCU for 90 consecutive days compared to those without sepsis (10% versus 5.1%, OR 2.05 [95% CI 1.99-2.11]), and spent more time as a top 1% HCU (18.5% of time versus 10.8% of time, RR 1.68 [95% CI 1.65-1.70]).

CONCLUSIONS: The sequelae of sepsis result in higher healthcare costs with important economic implications. After discharge, individuals who experienced sepsis are more likely to be a HCU and spend more time as a HCU compared to individuals who did not experience sepsis during hospitalization.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Barrett KA, Sheikh F, Chechulina V, et al. High-cost users after sepsis: a population-based observational cohort study. Crit Care. 2024. PMID: 39434142. doi:10.1186/s13054-024-05108-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。